The key works there is ULTIMATELY hyperopia. I said in an ultimately robust manufacturing process the should be able to overcome this limit because all the work is done INSIDE of a cartridge, that this is 1.0, and an implementation of their original system that was not made for a robust manufacturing process and your notion that there was a forever limit on manufacturing based on this original machine is not how commercial manufacturing works in the long run. I also said I do not know how they will implement it initially, but it very well likely will be with the simple machine but then that is not ultimately straight through automation. Ultimately a manufacturing process would work toward straight through manufacturing such that they would not have to intervene to bottle the product and process it. That is pretty much how you ultimately organize any manufacturing process.
Yes, initially the model t was made by craftsmen, in a line, one would do the seats, another the steering wheel, etc., and then year by year they figured out how to automate that process until today. Now we have much more sophisticated industrial processes and engineers, but version 1.0 probably could be as you and I originally suggested, just putting the same old machines you saw into the factory, but my main point is that you can’t possibly predict their forever top limit when that is how manufacturing and total quality management works, all manufacturing really, with continuous improvement over time. And yes, with drugs this happens too.
These are still the early days of manufacturing.
Yes, that is an INITIAL prototype and not all that different from past prototypes except customized for now to make DCVax-L. It said an “Initial Funding Prototype”. Meaning it is the first prototype.
My original point was the reason you do all the work in a cartridge is so that you can ultimately to parallel processing more easily. You did not seem to understand my point which was a basic one for understanding how well positioned the company is for true industrialization, not just putting a lineup of lab machines into a large setting. When they have enough resources and true industry people running this, and some time has gone by to understand their opportunities for efficiencies, I do expect that they may arrange the process differently and typically what happens from an initial manufacturing process to a more mature one is that the industrial scaling opportunities become immense and companies can go from making one product at a time with one employee, to more and more and more product. Thus it is very difficult to take a 1.0 process and say that will last forever.
